S021 How Would You Reconstruct It
DESCRIPTION
This is essentially a Masters of Reconstruction panel. Each of the speakers presents two or three interesting cases that have multiple options for closure. The panel then discusses how they would approach the defect. Finally, the speaker will reveal how they closed the wound, why it worked or did not work, and what they learned from the case.
LEARNING OBJECTIVES
Recognize the• Analyze a defect and design multiple closure options
Describe the reasoning behind why one closure was chosen over another
Discuss what goes into the decision making of outstanding surgical reconstruction
SCHEDULE
9:00 AM
Introduction
Thomas E. Rohrer, MD, FAAD
9:02 AM
Educational cases from Pittsburg
David G. Brodland, MD, FAAD
9:20 AM
Educational cases from Houston
9:40 AM
Educational cases from New York
10:00 AM
Educational cases from Vancouver
Iren Kossintseva, MD
10:20 AM
Educational cases from St Louis
Martha Laurin Council, MD, MA, MBA, FAAD
10:40 AM
Educational cases from Palo Alto
Greg S. Morganroth, MD, FAAD
11:00 AM
Educational cases from San Francisco
Siegrid S. Yu, MD, FAAD
11:20 AM
Educational cases from Thousand Oaks
Andrew J. Kaufman, MD, FAAD
11:40 AM
Educational cases from Columbus
David R. Carr, MD, MPH, FAAD
11:55 AM
Closing Remarks
Anna A. Bar, MD, FAAD
11:55 AM
Discussion
DIRECTOR
Thomas E. Rohrer, MD, FAAD
SkinCare Physicians
SPEAKERS
Anna A. Bar, MD, FAAD
Jeremy S. Bordeaux, MD, MPH, FAAD
David G. Brodland, MD, FAAD
Zitelli Brodland’s and Lim Skin Cancer Center
David R. Carr, MD, MPH, FAAD
The Ohio State University
Martha Laurin Council, MD, MA, MBA, FAAD
Andrew J. Kaufman, MD, FAAD
Clinical Professor, Keck School of Medicine of USC
Greg S. Morganroth, MD, FAAD
Siegrid S. Yu, MD, FAAD
University of California, San Francisco
DISCLOSURES
Anna A. Bar, MD, FAAD
Castle Biosciences – Investigator(Other Financial Benefit); Regeneron – Consultant(Honoraria);
Jeremy S. Bordeaux, MD, MPH, FAAD
No financial relationships exist with ineligible companies.
David G. Brodland, MD, FAAD
No financial relationships exist with ineligible companies.
David R. Carr, MD, MPH, FAAD
Regeneron – Investigator(No Compensation Received); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria);
Martha Laurin Council, MD, MA, MBA, FAAD
Castle Biosciences – Investigator(Grants/Research Funding); Sanofi/Regeneron – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Andrew J. Kaufman, MD, FAAD
No financial relationships exist with ineligible companies.
Greg S. Morganroth, MD, FAAD
No financial relationships exist with ineligible companies.
Thomas E. Rohrer, MD, FAAD
Acclaro Medical – Advisory Board(Fees); Candela Corporation – Advisory Board(Honoraria), Speaker(Honoraria); UpToDate – Other(Honoraria);
Siegrid S. Yu, MD, FAAD
No financial relationships exist with ineligible companies.